Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 44 EP applications Carlos E. Salud has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11774034

GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE ANALOGS

IPC classification:
A61P 3/00, C07K 14/605
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11776453

USE OF ACTIVE PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CONDITIONS

IPC classification:
A61P 25/28, A61K 31/551, A61K 31/4439
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11791572

NOVEL TRIAZOLE COMPOUNDS III

IPC classification:
A61P 25/00, A61K 31/4192, C07D 491/107, C07D 417/14, C07D 413/14, C07D 405/14, C07D 403/04, C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11799718

NEW BIARYL AMIDE DERIVATIVES

IPC classification:
A61P 13/12, A61K 31/337, C07D 417/14, C07D 413/14, C07D 413/12, C07D 405/14, C07D 405/12, C07D 305/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12706050

NOVEL BENZODIOXOLE PIPERIDINE COMPOUNDS

IPC classification:
A61K 31/36, C07D 413/14, C07D 409/14, C07D 405/14, C07D 405/04, A61P 25/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12708335

NEW AZASPIRODECANONE COMPOUNDS

IPC classification:
A61K 31/403, C07D 491/113, C07D 491/107, C07D 403/08, C07D 401/14, C07D 401/08, C07D 401/04, C07D 209/54, A61P 3/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12708036

SEC-HYDROXYCYCLOHEXYL DERIVATIVES AS HSL INHIBITORS FOR THE TREATMENT DIABETES

IPC classification:
A61K 31/402, C07D 209/54, A61P 9/00, A61P 3/00, A61P 1/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12709886

NEW AZASPIRODECANONE COMPOUNDS AS HSL INHIBITORS

IPC classification:
A61K 31/427, A61K 31/422, A61K 31/4178, A61K 31/403, C07D 417/06, C07D 413/06, C07D 403/06, A61P 29/00, A61P 9/00, A61P 3/10, A61P 3/04, A61P 3/00, A61P 1/16
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12717736

ISOINDOLINONE DERIVATIVES

IPC classification:
A61K 31/497, A61K 31/4155, C07D 403/12, A61P 3/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12719356

NOVEL BENZOFURANE-PIPERIDINE COMPOUNDS

IPC classification:
A61K 31/4525, A61K 31/343, C07D 405/10, A61P 25/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12772788

PROCESS FOR THE PREPARATION OF ISOXAZOLYL-METHOXY-NICOTINIC ACIDS

IPC classification:
C07D 487/04, C07D 413/14, C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12772789

SOLID FORMS OF 1,L-DIOXO-4-THIOMORPHOLINYL)-[6-[[3(4-FLUOROPHENYL)-5-METHYL-4-ISOXAZOLYL]METHOXY]-3-PYRIDINYL]-METHANONE

IPC classification:
A61K 31/541, C07D 401/12, A61P 25/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12713846

ANTI-FGFR4 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Genentech, Inc.
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12189107

Indol-amide compounds as beta-amyloid inhbitors

IPC classification:
A61K 31/497, A61K 31/454, A61K 31/404, C07D 405/14, C07D 405/04, C07D 403/06, C07D 403/04, C07D 401/14, C07D 401/06, C07D 401/04, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
APPLICATION REFUSED
EP13774129

CELL PENETRATING PEPTIDES WHICH BIND IRF5

IPC classification:
C07K 14/47
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13774418

MACROCYCLIC KETOAMIDE IMMUNOPROTEASOME INHIBITORS

IPC classification:
A61K 38/05, C07K 5/065, C07K 5/062, A61P 29/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13767013

KETOAMIDE IMMUNOPROTEASOME INHIBITORS

IPC classification:
C07K 5/00, A61P 29/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13798328

SUBSTITUTED TRIAZOLE BORONIC ACID COMPOUNDS

IPC classification:
A61K 31/69, C07F 5/02, A61P 29/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13799602

NOVEL BI-RING PHENYL-PYRIDINES/PYRAZINES FOR THE TREATMENT OF CANCER

IPC classification:
C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14769665

POLYCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
A61P 3/00, A61P 3/10, A61P 3/04, A61K 31/426, A61K 31/4152, C07D 277/20, C07D 231/10
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14813526

AZETIDINE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
A61P 35/00, A61K 9/08, A61K 9/06, A61K 31/397
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14812952

ESTROGEN RECEPTOR MODULATOR AND USES THEREOF

IPC classification:
A61P 35/00, A61K 9/48, A61K 9/20, A61K 31/397
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP11779633

Triazole derivatives as ligands for Gaba receptors

IPC classification:
A61P 25/28, A61K 31/427, A61K 31/4192, A61K 31/4155, C07D 417/14, C07D 417/06, C07D 413/14, C07D 405/14, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15154342

Compounds for the treatment of cancer

IPC classification:
A61K 31/551, A61K 31/502, A61K 31/501, A61K 45/06, A61P 35/00, A61K 31/5377, A61K 31/506, A61K 31/4709, A61K 31/4545, A61K 31/454, A61K 31/4436, A61K 31/438, A61K 31/437, A61K 31/4353, A61K 31/435, A61K 31/433
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
APPLICATION REFUSED
EP11778911

TRIAZOLE DERIVATIVES AND THEIR USE FOR NEUROLOGICAL DISORDERS

IPC classification:
A61P 25/00, A61K 31/497, A61K 31/4439, A61K 31/4192, C07D 491/107, C07D 471/04, C07D 413/14, C07D 409/14, C07D 405/14, C07D 403/14, C07D 403/12, C07D 403/10, C07D 401/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15166641

SOLID FORMS

IPC classification:
C07C 211/36, C07C 209/84, C07C 209/62
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
APPLICATION PUBLISHED
EP14827261

ESTROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC ESTROGEN RECEPTOR POSITIVE BREAST CANCER

IPC classification:
A61P 35/00, A61P 35/04, A61K 31/416
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15709908

METHODS AND COMPOSITIONS FOR MODULATING ESTROGEN RECEPTOR MUTANTS

IPC classification:
A61K 31/5375, A61K 31/428, A61K 31/4245, A61K 31/416, A61K 31/4025, A61K 31/397
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15721608

MORPHOLIN-PYRIDINE DERIVATIVES

IPC classification:
A61P 25/00, A61K 31/4245, C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15717916

GLYT1 INHIBITORS FOR USE IN THE TREATMENT OF HEMATOLOGICAL DISORDERS

IPC classification:
A61P 7/00, A61K 31/496, A61K 31/495, A61K 31/437, A61K 31/4035
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15721701

COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY

IPC classification:
A61P 21/00, A61K 31/5025, C07D 519/00, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15751037

SUBSTITUTED PYRAZINO[2,1-A]ISOQUINOLINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS

IPC classification:
A61P 25/00, A61P 3/00, A61K 31/436, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15810659

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
C07D 411/02, C07D 493/04, C07D 207/08, C07D 205/04, C07D 417/14, C07D 417/02, C07D 413/02, C07D 409/02, C07D 403/14, C07D 403/02, A61K 31/4025, A61K 31/397, C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17176794

PROCESS FOR THE PREPARATION OF N-[3-(AMINOMETHYL)OXETAN-3-YL]CARBAMATE INTERMEDIATES

IPC classification:
C07D 305/06, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16717143

TETRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS

IPC classification:
A61P 25/00, C07D 257/06, C07D 257/08, A61K 31/41, C07D 409/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16726087

IMIDAZOLE DERIVATIVES

IPC classification:
A61P 25/18, A61K 31/4164, C07D 233/64, C07D 233/60
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16729504

HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
C07D 491/052, C07D 405/12, C07D 405/04, C07D 405/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16727661

ETHYNYL DERIVATIVES

IPC classification:
A61P 1/00, A61P 25/00, A61K 31/4439, C07D 401/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16728915

TARGETED NOTCH PATHWAY INHIBITORS

IPC classification:
A61P 13/12, A61K 31/553, C07D 267/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16738155

CRYSTALLINE FORMS OF N-[(3-AMINO-3-OXETANYL)METHYL]-2-(2,3-DIHYDRO-1,1 -DIOXIDO-1,4-BENZOTHIAZEPIN-4(5 H)-YL)-6-METHYL-4-QUINAZOLINAMINE FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS

IPC classification:
A61P 31/12, A61K 31/5415, C07D 417/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16739442

ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS

IPC classification:
A61P 25/00, A61K 31/527, C07D 491/20, C07D 491/107, C07D 487/10, C07D 471/10, C07D 401/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16736493

2-PHENYL-6-IMIDAZOLYL-PYRIDINE-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS EAAT3 INHIBITORS

IPC classification:
A61P 25/18, A61K 31/4439, C07D 409/14, C07D 401/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16745473

ETHYNYL DERIVATIVES

IPC classification:
A61P 25/16, A61K 31/519, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16748125

PYRIDINE AND PYRIMIDINE DERIVATIVES

IPC classification:
C07D 213/56, C07D 239/36, C07D 403/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature